The Cancer in the Family Clinical Decision Support Tool (Text Version) Slide presentation from the AHRQ 2010 conference. On September 28, 2010, Linda Squiers made this presentation at the 2010 Annual Conference. Select to access the PowerPoint® presentation (3.8 MB). Free PowerPoint® Viewer (Plugin Software Help).Slide 1The Cancer in the Family Clinical Decision Support ToolLinda Squiers, PhDModerated by: Gurvaneet Randhawa, MDSeptember 2010www.rti.orgNote: Every slide has the RTI International logo on the bottom right-hand side.Slide 2RTI Study TeamRobert Furberg, MBALauren McCormack, PhDRoger Osborn, BSEric Peele, BADoug Rupert, MPHClaudia Squire, MSJanice Tzeng, MPHNedra Whitehead, PhD, MS, CGCSue West, PhDSlide 3The tool should...Be user-friendly and computerized.Easily updated and maintained.Capable of working on different IT platforms, systems, and architecture.Empirically and accurately assess patients' risk of BRCA mutations and provide results via cancer family history.Encourage patient-provider communication.Educate patients on HBOC, BRCA mutations, genetic counseling and BRCA testing.Encourage patients to share cancer family history.Educate providers risk for HBOC, including USPSTF recommendations about referring patients for BRCA counseling and testing.Slide 4Development ChallengesMotivation: providers and patients: Provider priorities: clinicians not trained in genetics, perceived risk, perceived benefit.Only a small minority of women will be at increased risk. How can the tool help women who are not at increased risk for BRCA mutations?Collecting family history: Providers and patients unsure about what a complete family history includes.Asking relatives about cancer history.Length of time to gather and enter cancer family history.Integration with EMRs.Slide 5Development of Cancer in the Family ToolAn image of a flowchart labeled "Development of Cancer in the Family Tool" is shown.Slide 6Patients—Steps in Using the ToolFlowchart: Tool Login (Home) → Step 1: Learn about HBOC and BRCA → Step 2: Decide Whether to Gather Family History & Learn Risk →Step 3: Collect Family History↓Step 4: Calculate BRCA Risk → Step 5: Understand Risk → Step 6: Action Plan → Clinic Visit Review Risk with ProviderSlide 7Login ScreenThis is a screen shot of the login page for the tool. Users login with a user name and password on the left side. A welcome message appears in the center. To the far right, is an icon that can be selected to launch a video that takes the user on a tour of the Web site.Slide 8Patient Interface—IntroductionThis is a screenshot of the patient tool's introduction page that outlines the 6 steps of the tool: Step 1: Learn; Step 2: Decide; Step 3: Gather; Step 4: Calculate; step 5: Know; and Step 6: Plan.Slide 9Patient Interface—Step 2: DecideThis is a screenshot of the patient tool, Step 2: Decide, which displays a decision point where patients need to decide if they want to continue on to collect their family history.Slide 10Patient Interface—Step 3: GatherThis is a screenshot of the patient tool, Step 3: Gather, which discusses how to gather your family's history of cancer.Slide 11 Patient Interface—Step 3: GatherThis is a screenshot of the patient tool, Step 3: Gather, with a display of the "Create Your Family Tree - Siblings" section.Slide 12Patient Interface—Step 3: GatherThis is a screenshot of the patient tool, Step 3: Gather, which displays the section where patients enter in their family members' history of breast and ovarian cancer.Slide 13Patient Interface—Step 3: GatherThis is a screenshot of the patient tool, Step 3: Gather, which shows the family tree that is produced by the tool. It uses male and female gender symbols, and includes the relationship for each family member (e.g., brother) and their age.Slide 14Patient Interface—Step 4: CalculateThis is a screenshot of Step 4: Calculate, of the tool. It displays the patient's risk results in a box at the bottom of the page.Slide 15Patient Interface—Action PlanThis is a screenshot of the patient's action plan produced by the tool. It displays the patients risk results and tips for talking to your doctor.Slide 16Providers—Steps in Using the ToolStep 1: Explore ToolBRCA BasicsBeyond BasicsSharing Risk ResultsStep 2: See Study Patients(Use Tool During Visit)Review Family HistoryReview BRCA RiskReview Screening Recommendations ← Includes USPSTF cancer screening recommendations (e.g., Pap, cervical cancer)Provide Genetic Counseling Referral (if appropriate)Step 3: Complete ChecklistEach Patient VisitSlide 17Provider Interface—Patient ListThis is a screenshot of the provider interface of the tool where providers find the study patient.Slide 18Provider Interface—BRCA BasicsThis is a screenshot of the BRCA Basics content page in the provider interface.Slide 19Provider Interface—Beyond BasicsThis is a screenshot of the Beyond Basics page in the provider tool.Slide 20Provider Interface—Sharing ResultsThis is a screenshot of the Sharing Results page in the provider tool.Slide 21Provider Interface—Additional ResourcesThis is a screen shot of the Additional Resources page in the provider interface. It provides links to other information pages on hereditary cancer and treatments.Slide 22Provider Interface—Patient Risk ResultsThis is screenshot of the provider printout which includes the patient's risk results in numeric form.Slide 23Provider Interface—Patient Risk ResultsThis is a screenshot of the family history data in table format included in the provider printout.Slide 24Usability TestingPatients (n=8)Education4 high school graduates3 some collegeSlide 25Usability TestingPatients (n=8)Education4 high school graduates3 some college1 college graduateAge3 were 18-344 were 35-491 was 50-64Race3 African American4 White1 Asian5 had a family history of breast/ovarian cancerProviders (n=6)Providers sent link approximately 1 week before interview: Asked to review and complete a worksheet.Then interviewed by RTI interviewer.Provider Type 2 preventive medicine residents3 family medicine MD1 OB-GYN5 females/1 maleSlide 26Modifications to Patient Interface Based on Usability TestingClarifying language about risk (mutations vs. cancer risk).Security features (concerns about PHI): Added RTI's Privacy Policy at bottom of home page.Password protected accounts.Eliminate full names for cancer family history.Store data on RTI's secure server.Provided clarifications on instructions on using the tool: Instructional tips throughout the tool, especially in introduction.Side bar navigation steps numbered.Step 3: Gather—broken down into several sub-steps.Pedigree renamed Family Tree and Health History and modified with new symbols: B1, B2 and ODropped age at diagnosisSize of legend increasedSlide 27Issues Raised in Provider Usability TestingImages (e.g., male mammography technician and physicians)Content Make more concise by using succinct, bulleted content collapsed beneath each subheadingReorganize Beyond Basics and make less redundant with BRCA BasicsIdentifying patients Patient username convention developedCan sort alphabetically and by appointment dateOutput Made physician version of risk results Use numeric risk and categorical riskInclude pedigree and tablePDFDevelop Visit Summary PDF (for future)Slide 28Take-a-Tour Video for Patient ToolGoal: develop a brief, persuasive, and engaging multimedia asset that effectively communicates the purpose of the tool, the importance of BRCA screening, and the estimated burden associated with the tool.7-8 minutes.Voice over narration.Native resolution in high definition, but delivered through Flash.Slide 29Pilot Testing OverviewSlide 30EvaluationImplementation Evaluation: Was the tool used as planned?Outcome Evaluation: What are the potential effects of the tool on patients and providers?Pilot Evaluation Procedures, Instruments, and Processes: How well did the evaluation protocol work?Slide 31Pilot Testing OverviewTimelineApril-June 2010 (8 weeks)Clinical SitesBaylor Health Care System (Dallas, TX)Fairfax Family Practice (Fairfax, VA)Slide 32Pilot Testing ParticipantsPatient ParticipantsWomen with scheduled annual examsAge 21-60, English fluencyNo personal cancer historyResidential access to computer / WebProvider ParticipantsPrimary care providerScheduled to see patients during pilotNumber of providers involved varies by siteSlide 33Pilot Study SitesSiteProviders(n=9)Patients(n=48)BHCS Garland317BHCS Southlake319Fairfax312Patient and provider samples not representativeSlide 34BRCA Risk Results (n=48)Increased Risk (n=2) 4.2%Not at Increased Risk (n=44) 91.6%Missing/Don't Remember (n=2) 4.2%Slide 35 Perceived Accuracy and Satisfaction Accuracy of Risk ResultsVery accurate (n=18) 37.5%Somewhat accurate (n=18) 37.5%Satisfied with Decision to Learn RiskVery satisfied (n=27) 56.3%Somewhat satisfied (n=10) 20.8%Slide 36Family History Collection75% entered some or all family cancer history.71% said very easy or easy to enter history.75% found worksheet useful or very useful.73% printed results of risk assessment.65% brought printout to doctor's visit.Slide 37Percent of Patients that Rated Tool as Very Effective or Effective....in helping them understand...80% BRCA mutations.79% Advantages/disadvantages of learning risk.70% Results of BRCA risk assessment.79% Satisfied or very satisfied with tool.Slide 38Patient Knowledge about Risks of Breast and Ovarian Cancer (n = 48)ItemBaselinePosttest 1A woman who does not have a BRCA1 or BRCA2 gene mutation can still get cancer. True*27 (43.8%)43 (89.6%)False0 (00.0%)0 (00.0%)Don't know21 (43.8%)4 (08.3%)Missing0 (00.0%)1 (02.1%)A woman who has a BRCA1 or BRCA2 gene mutation. Will definitely get breast or ovarian cancer0 (00.0%)1 (02.1%)Is at lower risk for breast or ovarian cancer0 (00.0%)0 (00.0%)Is at greater risk for breast or ovarian cancer*26 (54.2%)45 (93.8%)Don't know22 (45.8%)0 (00.0%)Missing0 (00.0%)1 (02.1%)Your chances of having a BRCA1 or BRCA2 gene mutation is based on... Whether your mother had breast cancer and/or ovarian cancer2 (04.2%)0 (00.0%)Your entire family history of all diseases7 (14.6%)1 (02.1%)Your entire family history of breast and ovarian cancer*17 (35.4%)44 (91.7%)Don't know22 (45.8%)0 (00.0%)Missing0 (00.0%)1 (02.1%)A BRCA genetic test cannot tell you... If you have a BRCA1 or BRCA2 mutation2 (04.2%)0 (00.0%)If you will get breast and/or ovarian cancer*25 (52.1%)42 (87.5%)If you have a greater chance of breast and ovarian cancer0 (00.0%)1 (02.1%)Don't know21 (43.8%)4 (08.3%)Missing0 (00.0%)0 (00.0%)* Correct AnswerSlide 39Provider FindingsSlide 40Educational ModuleQuality of InformationExtremely high 56%High 33%Made Me Feel More ConfidentStrongly agree 56%Agree 44%Learned a Great DealStrongly agree 22%Agree 56%Slide 41Clinical Visit ActivitiesReferrals ProvidedGenetic counseling 4%Mammography 60%Pap test 44%Visit ActivitiesReviewed patient's family history 88%Updated patient's family history 67%Explained risk result 88%Addressed questions about risk 83%Slide 42Provider Checklist Responses Following Visit with Patient (n = 9 providers for 48 patients)When did you use the tool to review this patient's risk resultsNo.(%)Before patient's appointment16(33.3%)During patient's appointment22(45.8%)Both before and during patient's appointment4(8.3%)Did not use tool4(8.3%)Missing2(4.2%)Slide 43Tool PerceptionsEase of UseBaseline*Post-Study*Tool is clear and understandable3.04.3Tool will be easy to use2.34.2Trialability Can properly try out tool before using it in practice3.04.5Tool will take too long to learn2.71.8* Responses on a strongly agree (5)—strongly disagree (1) scaleSlide 44Tool PerceptionsEase of UseBaseline*Post-Study*Tool will likely improve clinical care4.44.0Tool will be useful for patients4.34.4Workflow Effects Tool will allow me to accomplish tasks more quickly1.82.8Tool will fit well with the way I like to work3.33.8Tool will be compatible with workflow2.83.3* Responses on a strongly agree (5)—strongly disagree (1) scaleSlide 45ConclusionsPatient and provider outcomes positive.Evaluation protocol worked well. Recruit challenging. Getting through to participants via phone was difficult.Email may help.No major redesign needed. Enhancements to printouts desired.Produce appointment summary for providers.Additional references and resources.Slide 46Future StudiesUse a control or comparison group. Important to assess proportion of patients in primary care population at increased risk.High risk cutoff of 0.01 used. We recommend 0.02 for future studies.Randomly select clinic sites.Ensure more representative patient and provider population.Alternate ways of using the tool: Providers could discuss results with patients by phone. Use different types of providers to discuss results (e.g., nurse).Patient tool could be stand alone tool.Develop the current tool to transfer risk results to EMR.Slide 47For DiscussionSlide 48Surgeon General's My Family Health PortraitNew version released 1/2009Web-basedFamily history can be downloaded to individual's computer and sharedStandards based, customizable and open source allowing for use in EHRs or CDSIncludes history for 15 common diseases and other to be addedNow allows addition of family members beyond 1st and 2nd degree relativesLimitationsAge at diagnosis is collected by age category rather than actual age which affects risk calculation in BRCAPRODoes not ask if breast cancer was unilateral or bilateralLimited cognitive and usability testing prior to releaseSlide 49Other Available Interactive ToolsInteractive Cancer Family Tree, University of Nebraska Medical Center: http://app1.unmc.edu/gencancer/MyGenerations, NorthShore University Health System's Center for Medical Genetics, Illinois: http://www.northshore.org/genetics/mygenerations/Family HealthLink, The Ohio State University Medical Center: https://familyhealthlink.osumc.edu/Notice.aspxBreast Cancer Genetics Referral Screening Tool (B-RST): http://www.brcagenscreen.org/Slide 50Future IT Development ProjectsInclude more thorough formative research: Interviews or focus groups with user groups.Cognitive testing of draft content.Multiple rounds of usability testing.Slide 51Results from ITS Feasibility Assessment: EMR IntegrationOperating Systems and Internet AccessPractices have restricted access to many outside Web sites (especially those with video).Electronic Medical Records (EMRs)EMRs cannot be linked to outside tools or systems to protect patient privacy without arduous review and approval.Tool-EMR integration is strongly desired by physicians, who want to document patients' BRCA risk results within existing medical records.Patients cannot access their EMRs to view results or enter/update family history.Test results and tool output cannot be sent directly to EMRs. However, staff can manually scan or save visual files into the system.Physicians and practices are adverse to the time/cost of maintaining a tool themselves. Current as of December 2010 Internet Citation: The Cancer in the Family Clinical Decision Support Tool (Text Version). December 2010. Agency for Healthcare Research and Quality, Rockville, MD. http://www.ahrq.gov/news/events/conference/2010/squiers/index.html